Expanded approval for buccal fentanyl not recommended.

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1638, 2008-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Verteporfin recommended for approval in the EU

Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Fentanyl Effervescent Buccal Tablets: Enhanced Buccal Absorption

By Durfee Steven

American Journal of Drug Delivery, Vol. 4, Iss. 1, 2006-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Fentanyl buccal tablet: profile report

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 5, 2007-05 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl Pharmacokinetics

By Darwish Mona

Clinical Pharmacokinetics, Vol. 45, Iss. 8, 2006-01 ,pp. : 843-850

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy Volunteers

By Darwish Mona

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1279-1286

Adis International

Access to resources Recommend Favorite